Conquering Diseases

Study Of An Investigational Drug For Duchenne Muscular Dystrophy (Dmd)

Description

Seeking boys with Duchenne Muscular Dystrophy for a study of an investigational gene therapy drug.

Overview

We are comparing the investigational drug to a placebo (which looks like the drug but doesn't contain medicine) to see if the investigational drug is safe and effective in improving muscle function for boys with Duchenne Muscular Dystrophy. All participants will receive the investigational drug for one year and the placebo for one year, but neither they nor their healthcare providers will know which one they receive first.

What we're hoping for

We hope that the investigational drug will help boys with Duchenne Muscular Dystrophy to make dystrophin within their own bodies and that this will improve their muscle function.

Additional Information

ClinicalTrials.gov Identifier: NCT04281485

 Principal Investigator

Brenda  Wong, MD

UMass Memorial Health Care

 Study Contact

Sarah  Figueira

508-856-1604

sarah.figueira@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989